GlassScriptPhysician profile
Michael Anthony Gajewski
NPI 1629553755
$62,145.72
in general payments reported to CMS, 2019-2025
27 companies · $50K in 2025
The $50K reported for 2025 was more than what 99% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $305 · 2023: $2,663 · 2024: $8,699 · 2025: $50K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Food and Beverage: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Travel and Lodging: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,400.00 |
| Food and Beverage | $13,586.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,631.25 |
| Travel and Lodging | $11,223.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $38,040.51 | 2023-2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $8,865.14 | 2023-2025 | Jardiance |
| Lilly USA, LLC | $4,342.23 | 2024-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $3,502.44 | 2023-2025 | |
| Abbott Laboratories | $1,397.56 | 2023-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Alnylam Pharmaceuticals INC. | $1,111.64 | 2022-2025 | Onpattro, Amvuttra |
| Astrazeneca Pharmaceuticals LP | $1,064.74 | 2022-2025 | Farxiga, Wainua, Lokelma |
| Merck Sharp & Dohme LLC | $544.20 | 2022-2025 | Verquvo, Winrevair, Capvaxive |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $526.57 | 2022-2025 | Lifevest |
| Pfizer INC. | $491.35 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $484.42 | 2023-2025 | Camzyos, Eliquis |
| Actelion Pharmaceuticals US, INC. | $395.16 | 2022-2025 | Uptravi, Opsumit, Opsynvi |
| Novartis Pharmaceuticals Corporation | $274.30 | 2022-2025 | |
| Bridgebio Pharma, INC. | $267.64 | 2025 | Attruby |
| Lexicon Pharmaceuticals, INC. | $157.45 | 2023-2024 | Inpefa |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $148.22 | 2024 | Optimizer |
| Novo Nordisk INC | $118.59 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Scpharmaceuticals INC. | $113.33 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $70.82 | 2023 | Xarelto |
| Daiichi Sankyo INC. | $62.54 | 2022-2025 | Injectafer |
| Boston Scientific Corporation | $51.18 | 2022-2025 | Bodyguardian, Resonate El Icd Vr |
| Abiomed | $27.05 | 2025 | |
| Recor Medical INC | $25.02 | 2025 | Paradise Ultrasound Renal Denervation System |
| Ultragenyx Pharmaceutical INC. | $19.58 | 2024 | Dojolvi |
| Nuwellis, INC. | $15.01 | 2025 | Aquadex Smartflow Console |
| Baxter Healthcare | $14.58 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Medtronic, INC. | $14.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gajewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.